The first batch of 1 million doses of the locally produced coronavirus disease (COVID-19) vaccine has been distributed among 657 vaccination centers throughout Egypt, according to Health Minister Hala Zayed.
The jabs have been produced following a cooperation agreement between Chinese company Sinovac and Egypt’s Holding Company for Biological Products and Vaccines (Vacsera).
Vacsera manufactures and analyzes 15 million doses a month ahead of their distribution to vaccination centers nationwide.
Khaled Mujahid, assistant health minister, said the Vacsera-Sinovac vaccine obtained an emergency use license from the Egyptian Drug Authority on Aug. 23 following evaluation tests in accordance with the global standards and references followed by the World Health Organization to assess its safety, quality and effectiveness.
Mujahid said that an agreement was made to supply raw materials for the production of the vaccine in May. Vacsera medical teams and workers were trained by Chinese experts at a Sinovac facility, transferring vaccine manufacturing technology from China.
He added that the manufacture of the doses started on June 29, with three production cycles creating a total of 1 million doses.
Mujahid added that the vaccine was tested by the Vacsera control and quality laboratories, before being subjected to stability studies, noting that the samples were also analyzed in the laboratories of the Egyptian Drug Authority.